143 related articles for article (PubMed ID: 18827563)
21. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
Wu XX; Kakehi Y
Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study.
Stathopoulos GP; Boulikas T; Vougiouka M; Deliconstantinos G; Rigatos S; Darli E; Viliotou V; Stathopoulos JG
Oncol Rep; 2005 Apr; 13(4):589-95. PubMed ID: 15756428
[TBL] [Abstract][Full Text] [Related]
23. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
[TBL] [Abstract][Full Text] [Related]
24. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin.
Hrstka R; Powell DJ; Kvardova V; Roubalova E; Bourougaa K; Candeias MM; Sova P; Zak F; Fåhraeus R; Vojtĕsek B
Anticancer Drugs; 2008 Apr; 19(4):369-79. PubMed ID: 18454047
[TBL] [Abstract][Full Text] [Related]
25. MLH1-deficient tumor cells are resistant to lipoplatin, but retain sensitivity to lipoxal.
Fedier A; Poyet C; Perucchini D; Boulikas T; Fink D
Anticancer Drugs; 2006 Mar; 17(3):315-23. PubMed ID: 16520660
[TBL] [Abstract][Full Text] [Related]
26. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
Yang JX; Luo Y; Qiu HM; Tang WX
Saudi Med J; 2009 Jan; 30(1):35-40. PubMed ID: 19139770
[TBL] [Abstract][Full Text] [Related]
27. The effects of quercetin vs cisplatin on proliferation and the apoptotic process in A549 and SW1271 cell lines in in vitro conditions.
Borska S; Gebarowska E; Wysocka T; Drag-Zalesińska M; Zabel M
Folia Morphol (Warsz); 2004 Feb; 63(1):103-5. PubMed ID: 15039912
[TBL] [Abstract][Full Text] [Related]
28. Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
Meynard D; Le Morvan V; Bonnet J; Robert J
Oncol Rep; 2007 May; 17(5):1213-21. PubMed ID: 17390068
[TBL] [Abstract][Full Text] [Related]
29. 14-3-3sigma-dependent resistance to cisplatin.
Han Z; Dimas K; Tian X; Wang Y; Hemmi H; Yamada K; Kato N; Pantazis P; Ramanujam RJ; Anant S; Wyche JH; Houchen CW
Anticancer Res; 2009 Jun; 29(6):2009-14. PubMed ID: 19528459
[TBL] [Abstract][Full Text] [Related]
30. Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy.
Clingen PH; Wu JY; Miller J; Mistry N; Chin F; Wynne P; Prise KM; Hartley JA
Biochem Pharmacol; 2008 Jul; 76(1):19-27. PubMed ID: 18508035
[TBL] [Abstract][Full Text] [Related]
31. First safety and response results of a randomized phase III study with liposomal platin in the treatment of advanced squamous cell carcinoma of the head and neck (SCCHN).
Jehn CF; Boulikas T; Kourvetaris A; Kofla G; Possinger K; Lüftner D
Anticancer Res; 2008; 28(6B):3961-4. PubMed ID: 19192656
[TBL] [Abstract][Full Text] [Related]
32. [Preparation and biological activity of poly (gamma-glutamic acid) -cisplatin conjugate].
Jin L; Ye HF; Huang J; Jiang L; Hu RZ; Wu ZR
Yao Xue Xue Bao; 2007 Jun; 42(6):611-7. PubMed ID: 17702397
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.
Marzano C; Gandin V; Folda A; Scutari G; Bindoli A; Rigobello MP
Free Radic Biol Med; 2007 Mar; 42(6):872-81. PubMed ID: 17320769
[TBL] [Abstract][Full Text] [Related]
34. The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells.
Guay D; Garand C; Reddy S; Schmutte C; Lebel M
Cancer Sci; 2008 Apr; 99(4):762-9. PubMed ID: 18307537
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
Tayyem H; Huq F; Yu JQ; Beale P; Fisher K
ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
[TBL] [Abstract][Full Text] [Related]
36. CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis.
Boivin M; Lane D; Piché A; Rancourt C
Gynecol Oncol; 2009 Dec; 115(3):407-13. PubMed ID: 19747716
[TBL] [Abstract][Full Text] [Related]
37. [Effect of cisplatin on the expression of Pokemon gene: experiment with different human lung cancer cells].
Zhao ZH; Wang SF; Yu L; Wang J; Cong DG; Chang H; Wang XF; Zhang TW; Zhang J; Fu K; Jiang JY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1211-3. PubMed ID: 18844119
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of genes on 16q associated with cisplatin resistance of testicular germ cell tumor cell lines.
Wilson C; Yang J; Strefford JC; Summersgill B; Young BD; Shipley J; Oliver T; Lu YJ
Genes Chromosomes Cancer; 2005 Jun; 43(2):211-6. PubMed ID: 15761863
[TBL] [Abstract][Full Text] [Related]
39. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
[TBL] [Abstract][Full Text] [Related]
40. Ultrastructural change due to acquired cisplatin resistance in human bladder cancer cells.
Yoon SJ; Park I; Kwak C; Lee E
Oncol Rep; 2003; 10(5):1363-7. PubMed ID: 12883708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
